BIDMC researchers win Avon grant
Beth Israel Deaconess Medical Center investigators received a $300,000 grant from the Avon Foundation at the eighth annual Avon Walk for Breast Cancer Boston. The award was part of the $2.6 million in grants from the Avon Foundation to several local organizations.
The grant -- BIDMC's first from the Avon Foundation -- supports the research of Gerburg Wulf, MD, of the Division of Hematology/Oncology, and Joyce Fingeroth, MD, of the Division of Infectious Disease. The researchers are trying determine if acute infectious mononucleosis (AIM) or EBV-infection is a risk factor for breast cancer.
The Avon Walk Boston, the third of nine Avon walks this year, attracted more than 2,500 participants from 47 states, France and Bermuda, including 228 breast cancer survivors, who joined together to raise lifesaving funds and awareness for breast cancer.
Suze Orman, financial expert and special ambassador for the Avon Foundation, was on hand to announce the grants. She said, "They represent facilities that are doing cutting-edge research to find a cure and that offer services to patients regardless of their ability to pay. The new grants we present today will help them continue to save lives."
Caption: BIDMC investigators received a $300,000 grant from Avon Foundation at the annual Avon Walk for Breast Cancer Boston. From left are, Suze Orman, BIDMC investigators Joyce Fingeroth and Gerburg Wulf, and Carol Kurzig, president of Avon Foundation.